Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 August 2020 | Story Andre Damons
Follow these three easy steps to enter the Three-Minute Thesis Competition. Will you be this year’s winner?

 

The Three-Minute Thesis Competition, also known as the ‘3MT’, is an annual competition held at 200 universities around the world. It is open to PhD and master’s students, and challenges participants to present their research in just 180 seconds – in a way that is understood by an audience with no background in the research area. 


The UFS Postgraduate School was the first to bring the ‘Three-Minute Thesis’ (3MT) competition to Africa. The Three-Minute Thesis competition originates from the University of Queensland, Australia, and has now become an annual event at the UFS.

The competition aims to help participants develop presentation, research, and academic communication skills, as well as to support the development of research students’ ability to effectively explain their work. 
Although our country is in the midst of a pandemic, the annual competition continues. This year’s Three-Minute Thesis competition will be hosted online at
- The competition will first be hosted at the faculty level; faculty entries close at 14 August 2020

- Winners at faculty level will compete against each other at the Institutional level on 9 October 2020 and will stand a chance at winning these awesome cash prizes

UFS INSTITUTIONAL PRIZES FOR 2020 ARE:

Position Prizes 2020
Master’s winner R6 000
Master’s 1st runner-up R4 000
Master’s 2nd runner-up R2 000
PhD winner  R8 000
PhD 1st runner-up R6 000
PhD 2nd runner-up R4 000

 

Institutional winners will compete against other universities at the national level on 6 November 2020.


News Archive

Otorhinolaryngology research hopes to decrease morbidity
2016-10-04

Description: Prof Riaz Seedat Tags: Prof Riaz Seedat

Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS

Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.

He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.

Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.

The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.

Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.

“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.

“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept